Developing and Testing a Technology-Based Translation of the DPP to Address Prediabetes in a Primary Care Setting (DPPFit)
PreDiabetes, Metabolic Syndrome, Protection Against
About this trial
This is an interventional prevention trial for PreDiabetes focused on measuring mHealth, real-world setting, primary care intervention, diabetes prevention, remote, translation
Eligibility Criteria
Inclusion Criteria:
- Non-institutionalized adult patients
- Ages 18 - 55 years
- Diagnosed as prediabetes or with HbA1c% values between 5.7-6.4%.
Exclusion Criteria:
- Prior bariatric surgery
- Participation in weight loss program or current weight loss medication.
- History of T1DM or T2DM diagnosis
- Use of medications to treat glucose intolerance, including biguanides and sulfonylureas.
- History of infarction, angina, coronary artery bypass graft surgery, coronary angioplasty, congestive heart failure, or any condition that significantly limits their exercise such as peripheral arterial disease.
- BMI (kg/m²)< 18.5
Sites / Locations
- Augusta University - General Internal Medicine Clinic
Arms of the Study
Arm 1
Other
Enhanced Intervention Group (EIG)
The Enhanced Intervention Group was a subgroup of the participants that were invited for voluntary weekly meet-n-greet sessions in the Primary Care Clinic. These sessions were information and not educational sessions for the intervention. The entire EIG concept was to test a social component of participants by providing an informal opportunity for a DPPFit social group. The group sessions were terminated after only 5 weeks as a result of the Covid-19 pandemic. They were the only component of the DPPFit study that were face-to-face.